Stockreport

Ginkgo Bioworks acquires cell therapy assets from Modulus Therapeutics [Seeking Alpha]

Ginkgo Bioworks Holdings, Inc.  (DNA) 
PDF Financial terms of the deal were not disclosed. Modulus Therapeutics designs next-generation cell therapies for autoimmune diseases. The company has used its platform [Read more]